`
`
`
` DEPARTMENT OF HEALTH & HUMAN SERVICES
`
`
`
`
`
`
`Public Health Service
`
`Food and Drug Administration
`
`Rockville, MD 20857
`
`
`
`
`
`
`
`NDA 21-995/S-009
`
`
`
`Merck & Co., Inc.
`
`Attention: Richard J. Swanson, Ph.D.
`
`Director, Worldwide Regulatory Affairs
`
`P.O. Box 1000, UG2C-50
`North Wales, PA 19454-1099
`
`Dear Dr. Swanson:
`
`Please refer to your supplemental new drug application dated October 10, 2008, received
`October 10, 2008, submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act for
`Januvia (sitagliptin) Tablets.
`
`This “Changes Being Effected” supplemental new drug application provides for the addition of
`hepatic enzyme elevations under the Postmarketing Experience subsection of the Adverse Reactions
`
`section of the Package Insert. This supplement was submitted in response to our supplement
`request letter dated August 13, 2008.
`
`We completed our review of this application. This application is approved, effective on the date of
`this letter, for use as recommended in the agreed-upon labeling text, submitted on October 10, 2008.
`
`If you issue a letter communicating important information about this drug product (i.e., a “Dear
`
`Health Care Professional” letter), we request that you submit a copy of the letter to this NDA and a
`copy to the following address:
`
`
`
`
`
`
`
`
`
`
` MEDWATCH
`
`
`Food and Drug Administration
`Suite 12B05
`
`5600 Fishers Lane
`
`Rockville, MD 20857
`
`
`
`We remind you that you must comply with reporting requirements for an approved NDA
`(21 CFR 314.80 and 314.81).
`
`
`
`
`
`
`
`
`
`
`
`NDA 21-995/S-009
`Page 2
`
`If you have any questions, call Julie Marchick, Regulatory Project Manager, at (301) 796-1280.
`
`
`
`
`
`Enclosure: Package Insert, Patient Package Insert
`
`
`
`Sincerely,
`
` {See appended electronic signature page}
`
`Mary H. Parks, M.D.
`Director
`
`Division of Metabolism and Endocrinology Products
`Office of Drug Evaluation II
`Center for Drug Evaluation and Research
`
`
`
`---------------------------------------------------------------------------------------------------------------------
`This is a representation of an electronic record that was signed electronically and
`this page is the manifestation of the electronic signature.
`---------------------------------------------------------------------------------------------------------------------
`/s/
`
`---------------------
`Mary Parks
`
`10/20/2008 10:24:04 AM
`
`
`